Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ampreloxetine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theravance Biopharma Hosts Virtual KOL Event on Ampreloxetine
    Theravance Biopharma Hosts Virtual KOL Event on Ampreloxetine

    10 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-inc-to-host-virtual-key-opinion-leader-kol-event-to-discuss-ampreloxetines-potential-for-the-treatment-of-symptomatic-neurogenic-orthostatic-hypotension-noh-in-patients-with-multiple-system-atrophy-msa-302112659.html

    PR NEWSWIRE
    10 Apr 2024
    Share Share
    Theravance Biopharma to Present New Ampreloxetine Data
    Theravance Biopharma to Present New Ampreloxetine Data

    16 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-present-new-ampreloxetine-data-at-the-34th-international-symposium-on-the-autonomic-nervous-system-301990170.html

    PR NEWSWIRE
    16 Nov 2023
    Share Share
    Theravance Biopharma to Present New Ampreloxetine Data at the 2023
    Theravance Biopharma to Present New Ampreloxetine Data at the 2023

    28 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-present-new-ampreloxetine-data-at-the-2023-international-congress-of-parkinsons-disease-and-movement-disorders-301911054.html

    PR NEWSWIRE
    28 Aug 2023
    Share Share
    Ampreloxetine Data in Neurogenic Orthostatic Hypotension to be Presented
    Ampreloxetine Data in Neurogenic Orthostatic Hypotension to be Presented

    02 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/ampreloxetine-data-in-neurogenic-orthostatic-hypotension-to-be-presented-at-the-33rd-international-symposium-on-the-autonomic-nervous-system-301666725.html

    PRNEWSWIRE
    02 Nov 2022
    Share Share